Skip Navigation LinksHome > August 15, 2014 - Volume 66 - Issue 5 > Low Raltegravir Concentration in Cerebrospinal Fluid in Pati...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0000000000000222
Brief Report: Basic and Translational Science

Low Raltegravir Concentration in Cerebrospinal Fluid in Patients With ABCG2 Genetic Variants

Tsuchiya, Kiyoto PhD*; Hayashida, Tsunefusa PhD*; Hamada, Akinobu PhD†,‡; Kato, Shingo PhD§; Oka, Shinichi MD, PhD*,‖; Gatanaga, Hiroyuki MD, PhD*,‖

Collapse Box


Abstract: Adenosine triphosphate–binding cassette transporter G2 (ABCG2) is expressed on the cerebrospinal fluid (CSF) side of choroid plexus epithelial cells, which form the blood–CSF barrier. Raltegravir was recently identified as a substrate of ABCG2. In the present study, we analyzed the relationship between single-nucleotide polymorphisms of ABCB1 and ABCG2 genes and raltegravir concentrations in 31 plasma and 14 CSF samples of HIV-infected patients treated with raltegravir-containing regimens. The mean CSF raltegravir concentration was significantly lower in CA (25.5 ng/mL) and AA (<10 ng/mL) genotypes at position 421 in ABCG2 gene compared with CC (103.6 ng/mL) genotype holders (P = 0.016).

© 2014 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.